At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.

Live from the Future Nutra Innovation Summit, Kerry Hughes, founder and president of Ethnopharm, explains why botanicals' complex compound networks represent nutrition's next innovation frontier.

Nammex is bringing its already-introduced ErinaPrime Lion's mane mycelium ingredient, standardized to a specific neuroactive compound, to SupplySide Global.

Paul Eftang used his FNIS session to walk through lab data on lion's mane and Tongkat Ali products that pass identity and DNA testing while containing few or none of the bioactive compounds their marketing claims are based on.

At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.

Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.

At the Future Nutra Innovation Summit, SPINS' Scott Dicker presented data showing protein and performance nutrition account for 45% of total supplement growth, while sleep, cognitive health, reproductive health, and weight loss formulas have flattened or declined.

Live from the Future Nutra Innovation Summit, Cassie Evans, PhD, RD, explains what sets Helaina's effera human-identical lactoferrin apart in multiple aspects.